http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DK-2561860-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c33c9854af5f58d16ff7b2c305e037
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-125
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4748
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-048
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
filingDate 2003-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17572b479519fd29e88d2ba819a984bf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f913489f68fb0220a4ffe26d4156c125
publicationDate 2018-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DK-2561860-T3
titleOfInvention Implantable polymer device for prolonged release of buprenorphine
abstract The present invention provides compositions, methods, and kits for treatment of opiate addiction and pain. The invention provides a biocompatible nonerodible polymeric device which releases buprenorphine continuously with generally linear release kinetics for extended periods of time. Buprenorphine is released through pores that open to the surface of the polymeric matrix in which it is encapsulated. The device may be administered subcutaneously to an individual in need of continuous treatment with buprenorphine.
priorityDate 2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493286
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID4988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11274356
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452630670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419129972
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414865843
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID65088
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426326933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7904
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID114976
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491494
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507804
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID574141
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462328
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9848990
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18390
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488561
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87060462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415737932
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447628701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100379267

Total number of triples: 55.